Improving HIV-related Anal Health Services with PEACHES 2.0

This study is testing a program called PEACHES 2.0, which includes training and quality improvement strategies, to help healthcare providers offer and patients receive important anal health services. These services include testing for sexually transmitted infections (STIs) in the anal area, Doxy-PEP (a medication to prevent gonorrhea and chlamydia after sex), PrEP (a medication to prevent HIV), and anal cancer screening. The goal is to reduce stigma in healthcare settings so more people get these services. The study will involve staff and patients at eight clinics in the Mississippi Delta. Success will be measured by how many patients get anorectal STI screening. The study's current status is unclear, and it plans to enroll 8 participants.

Study design
This interventional study is testing a behavioral intervention called PEACHES 2.0. It plans to enroll 8 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Patient uptake of anorectal STI screening will be collected monthly for a total of 36 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07464236

Improving Clinic Delivery of HIV-related Anal Health Services

Not Yet Recruiting
NAAges 18+InterventionalHealth services
Albert Einstein College of Medicine
~8 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:PEACHES 2.0 Implementation Strategies

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient uptake of anorectal STI screening
Measured over Data will be collected monthly via the audit-and-feedback data dashboard. First data collection occurs just after month 1 of the Pre-Implementation period, continuing through Implementation and Maintenance periods, for a total of 36 months.
HIV
Gonorrhea
Chlamydia
Anal Cancer Squamous Cell
1 sites across 1 states
Mississippi1
  • Bryan Kutner, PhD, MPH · PRINCIPAL_INVESTIGATOR · Albert Einstein College of Medicine

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

employed at one of eight Coastal Family Health Center clinics at the time of the survey
over age 18 years old
accessing sexual health services at one of eight Coastal Family Health Center clinics in the last 12 months
over 18 years old

Exclusion

Staff or patients who are unable to provide informed consent (e.g., significant cognitive impairment)
Individuals currently incarcerated or in state custody
Patients whose only visits are for non-HIV, non-STI issues and who do not meet the EMR-based eligibility criteria above
  • Patient uptake of anorectal STI screeningData will be collected monthly via the audit-and-feedback data dashboard. First data collection occurs just after month 1 of the Pre-Implementation period, continuing through Implementation and Maintenance periods, for a total of 36 months.

    Clinics will extract deidentified patient level outcomes from the medical record system on a monthly basis. This data will be imported into an audit-and-feedback data dashboard developed by the PEACHES 2.0 team. For patient uptake of anorectal STI screening, the number of anorectal STI screening orders per month among all STI orders in that same month will be calculated, and the slopes across the three 12-month data collection periods: Pre-Implementation, Implementation, and Maintenance periods, will be compared.